Evidence map›Paper›PMID 31469835›Full record

ArticlePLoS neglected tropical diseases2019

IL-4 receptor dependent expansion of lung CD169+ macrophages in microfilaria-driven inflammation.

Frédéric Fercoq, Estelle Remion, Stefan J Frohberger, Nathaly Vallarino-Lhermitte, Achim Hoerauf, John Le Quesne, Frédéric Landmann, Marc P Hübner, Leo M Carlin, Coralie Martin

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Frédéric FercoqUnité Molécules de Communication et Adaptation des Microorganismes (MCAM, UMR 7245), Sorbonne Université, Muséum national d'Histoire naturelle, CNRS; CP52, Paris, France.ORCID 0000-0002-4825-024X
Estelle RemionUnité Molécules de Communication et Adaptation des Microorganismes (MCAM, UMR 7245), Sorbonne Université, Muséum national d'Histoire naturelle, CNRS; CP52, Paris, France.
Stefan J FrohbergerInstitute for Medical Microbiology, Immunology & Parasitology (IMMIP), University Hospital of Bonn, Bonn, Germany.
Nathaly Vallarino-LhermitteUnité Molécules de Communication et Adaptation des Microorganismes (MCAM, UMR 7245), Sorbonne Université, Muséum national d'Histoire naturelle, CNRS; CP52, Paris, France.
Achim HoeraufInstitute for Medical Microbiology, Immunology & Parasitology (IMMIP), University Hospital of Bonn, Bonn, Germany.
John Le QuesneLeicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom.
Frédéric LandmannCRBM, University of Montpellier, CNRS, France.
Marc P HübnerInstitute for Medical Microbiology, Immunology & Parasitology (IMMIP), University Hospital of Bonn, Bonn, Germany.
Leo M CarlinCRUK Beatson Institute, Garscube Estate, Bearsden, Glasgow, United Kingdom.
Coralie MartinUnité Molécules de Communication et Adaptation des Microorganismes (MCAM, UMR 7245), Sorbonne Université, Muséum national d'Histoire naturelle, CNRS; CP52, Paris, France.ORCID 0000-0003-3801-2595
Centre National de la Recherche Scientifique · FRUniversity Hospital Bonn · DECancer Research UK Scotland Institute · GBUniversity of Leicester · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L015129/1Cancer Research UK 23983Medical Research Council MC_UP_1203/1Medical Research Council MR/M01245X/1Wellcome TrustWellcome Trust 104931/Z/14/Z
6 · The paper itself

Abstract

Lung disease is regularly reported in human filarial infections but the molecular pathogenesis of pulmonary filariasis is poorly understood. We used Litomosoides sigmodontis, a rodent filaria residing in the pleural cavity responsible for pleural inflammation, to model responses to human filarial infections and probe the mechanisms. Wild-type and Th2-deficient mice (ΔdblGata1 and Il-4receptor(r)a-/-/IL-5-/-) were infected with L. sigmodontis. Survival and growth of adult filariae and prevalence and density of microfilariae were evaluated. Cells and cytokines in the pleural cavity and bronchoalveolar space were characterized by imaging, flow cytometry and ELISA. Inflammatory pathways were evaluated by transcriptomic microarrays and lungs were isolated and analyzed for histopathological signatures. 40% of WT mice were amicrofilaremic whereas almost all mutant mice display blood microfilaremia. Microfilariae induced pleural, bronchoalveolar and lung-tissue inflammation associated with an increase in bronchoalveolar eosinophils and perivascular macrophages, production of mucus, visceral pleura alterations and fibrosis. Inflammation and pathology were decreased in Th2-deficient mice. An IL-4R-dependent increase of CD169 was observed on pleural and bronchoalveolar macrophages in microfilaremic mice. CD169+ tissue-resident macrophages were identified in the lungs with specific localizations. Strikingly, CD169+ macrophages increased significantly in the perivascular area in microfilaremic mice. These data describe lung inflammation and pathology in chronic filariasis and emphasize the role of Th2 responses according to the presence of microfilariae. It is also the first report implicating CD169+ lung macrophages in response to a Nematode infection.

Indexed as

AnimalsDisease Models, AnimalFemaleFilariasisFilarioideaInflammationLungMacrophagesMice, Inbred BALB CReceptors, Interleukin-4Sialic Acid Binding Ig-like Lectin 1Th2 CellsReceptors, Interleukin-4Sialic Acid Binding Ig-like Lectin 1Siglec1 protein, mouse

Identifiers

PMID31469835
PMCPMC6742411
OpenAlexW2970238151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.